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ABSTRACT 
 
Cardiovascular diseases are still the predominant cause of death among the adult population in the 
Western world. Diseases such as myocardial infarction and stroke are caused by occluded blood 
vessels, as a result of atherosclerosis. Severely occluded vessels are preferably replaced with an 
autologous mammary artery or saphenous vein through by-pass surgery. Autologous replacement 
vessels are limited since many patients lack suitable vessels due to previous operations or have blood 
vessels that are inadequate for transplantation. Available synthetic vascular conduits function 
satisfactorily in large vessels. However, in small blood vessels (<6 mm), synthetic grafts are prone to 
thrombosis.  Thus, there is a need for alternative vascular graft material of biological origin. The main 
aim of this Thesis was to evaluate whether bacterial cellulose (BC) can be used as a biomaterial for 
engineered blood vessels.  
For an implant to be accepted in the host, it has to be biocompatible, i.e., be well integrated into the 
tissue and display appropriate properties. Biocompatibility studies of BC in hamster showed that the 
material does not induce inflammation and that both cells and microvessels grow into the BC. Thus, 
BC is well accepted in the tissue. Then, microporous BC was designed to further enhance 
biocompatibility. Smooth muscle cells (SMCs) cultured on porous BC migrated further into the 
material compared to cells grown on conventional BC. However, in contrast to conventional BC, 
porous BC elicited an inflammatory response characterized by macrophages, lymphocytes and 
myofibroblasts. Taken together, these results indicate that porous BC is inferior to conventional BC 
with regards to biocompatibility; nevertheless, microporosity improved cellular migration of SMCs in 
vitro. 
Additionally, the presence of the non-neuronal cholinergic system was evaluated in the vascular wall 
of the saphenous vein and cultured venous and arterial SMCs. Components of the non-neuronal 
cholinergic system were found in the media of the blood vessels as well as in cultured SMCs. Its 
function in these cells remains to be determined. 
This Thesis demonstrates that BC is biocompatible since it was found to be well integrated into 
surrounding tissues and therefore has good potential as a biomaterial for tissue engineering. 
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